AstraZeneca gets a new CFO and sees positive results from its cancer drug, Smurfit Kappa cements its leading position in Latin America, Mondi refinances its debt to link to its sustainability goals, Petropavlovsk’s partner faces regulatory problems, and Baltic Classifieds Group plots a London IPO.